ILMN
ILMN
NASDAQ · Life Sciences Tools & Services

Illumina Inc

$126.20
+0.22 (+0.17%)
As of Mar 25, 9:40 PM ET ·
Analyst Consensus
Hold
28
Analysts
High
Coverage
Buy 15 54%
Hold 10 36%
Sell 3 11%
Price Target
Analyst Price Target +34.2% upside
Low Target $114.37
Average Target $169.36
High Target $229.23
Current Price $126.20
Current
$126.20
Target
$169.36
$114.37 $169.36 avg $229.23
Scenario Analysis
Bear Case
$114.37
-9.4%
Low target
Base Case
$169.36
+34.2%
Avg target
Bull Case
$229.23
+81.6%
High target
Risk/Reward
8.7x
Highly favorable
Price in Context
52-Week High
$155.53
-18.9% from high
52-Week Low
$68.70
+83.7% from low
50-Day SMA
$136.22
-7.4% vs SMA
200-Day SMA
$108.49
+16.3% vs SMA
RSI (14)
17.5
Oversold
Target vs 52W High
$169.36
+8.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 33 88% $369.21 -24.8%
DHR
Danaher Corp
Strong Buy 30 87% $158.11 -15.5%
A
Agilent Technologies Inc
Buy 29 72% $64.69 -42.7%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -49.9%
MTD
Mettler-Toledo International
Hold 21 43% $170.43 -86.5%
ILMN
Illumina Inc
Hold 28 54% $169.36 +34.2%
WAT
Waters Corp
Buy 28 57% $189.60 -37.3%
WST
West Pharmaceutical Services
Strong Buy 23 78% $136.24 -44.8%